Everhart J E, Lombardero M, Lake J R, Wiesner R H, Zetterman R K, Hoofnagle J H
Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, USA.
Liver Transpl Surg. 1998 Jul;4(4):285-96. doi: 10.1002/lt.500040402.
Obesity is a concern in the long-term management of patients following liver transplantation, yet the risk of obesity and the factors that influence its development have not been well defined. We evaluated posttransplantation weight change among a cohort of 774 adults who had their height and weight recorded before liver transplantation at three major centers. Obesity was defined as a body mass index (BMI) of at least 30 kg/m2. Weight at transplantation was adjusted by the amount of ascites removed. Mean BMI increased from 24.8 kg/m2 pretransplantation to 27.0 kg/m2 in the first posttransplantation year, to 28.1 kg/m2 in the second year, and very little with subsequent observation. Among 320 patients who were not obese before transplantation, 21.6% became obese within 2 years after transplantation. On evaluation of numerous potential donor and pretransplantation risk factors, greater recipient BMI, greater donor BMI, and being married were found to be predictors of subsequent obesity (P < .05). Posttransplantation predictors of obesity included absence of acute cellular rejection, higher cumulative prednisone dose in the second year, and cyclosporine-based immunosuppression, although only rejection and prednisone dose remained predictors on multivariate analysis. Despite the marked weight gain after transplantation, prevalence of obesity at 2 years was only slightly greater than in the general US population. Obesity occurred commonly after liver transplantation, sometimes with a striking gain in weight. In addition to BMI at transplantation, donor BMI, marital status, occurrence of acute rejection, and prednisone dose affected the incidence of obesity.
肥胖是肝移植患者长期管理中的一个问题,然而肥胖风险及其发展的影响因素尚未明确界定。我们评估了774名成年人队列在肝移植后的体重变化,这些成年人在三个主要中心进行肝移植前记录了身高和体重。肥胖定义为体重指数(BMI)至少为30kg/m²。移植时的体重根据去除腹水的量进行调整。平均BMI从移植前的24.8kg/m²增加到移植后第一年的27.0kg/m²,第二年增加到28.1kg/m²,随后观察期间变化很小。在移植前不肥胖的320名患者中,21.6%在移植后2年内变得肥胖。在评估众多潜在的供体和移植前风险因素时,发现受者BMI较高、供体BMI较高和已婚是随后肥胖的预测因素(P<0.05)。移植后肥胖的预测因素包括无急性细胞排斥反应、第二年累积泼尼松剂量较高以及基于环孢素的免疫抑制,尽管在多变量分析中只有排斥反应和泼尼松剂量仍然是预测因素。尽管移植后体重显著增加,但2年时肥胖患病率仅略高于美国普通人群。肥胖在肝移植后很常见,有时体重会显著增加。除了移植时的BMI外,供体BMI、婚姻状况、急性排斥反应的发生以及泼尼松剂量都会影响肥胖的发生率。